国际麻醉学与复苏杂志   2018, Issue (8): 3-3
    
精细化麻醉管理在盆腔肿瘤手术中的应用研究
梁斌, 薛荣亮1()
1.宝鸡市中心医院
Study on the application of fine anesthesia management in pelvic tumor surgery
 全文:
摘要:

目的 研究精细化麻醉管理应用于盆腔肿瘤患者开腹手术全身麻醉的临床效果及安全性。 方法 选择96例盆腔肿瘤择期全身麻醉手术患者,ASA分级Ⅰ、Ⅱ级,按照随机数字表法分为经验组(A组)、精确控制组组(B组),每组48例;A组依据麻醉医师临床经验判断实施麻醉,B组联合使用仪器设备(包括麻醉深度监测仪、闭环肌松注射系统、心功能监护仪等)指导实施麻醉。在入室Narcotrend(NT)数值数据出现3 min后(T0)、插管后即刻(T1)、进腹(T2)、切除标本即刻(T3)、关腹(T4)、缝皮(T5)、意识恢复(T6)、气管拔管(T7)、出室(T8)等9个时间点,观察记录MAP、HR、呼吸频率(respiratory rate, RR)、SpO2;记录NT分级(Narcotrend stage, NTS)、NT指数(Narcotrend index, NTI)、肌松计数、四个成串刺激(train-of-four, TOF)值、每搏量变异率(stroke volume variation, SVV);记录各麻醉药用量、液体出入量、尿量、插管评级(按照Copper评分方法)、苏醒时间(停药至呼之睁眼的时间)、拔管时间(停药至拔管之间的时间)、出室时镇静评分(采用Ramsay评分法);记录副作用发生情况、ICU停留时间及手术至出院时间。 结果 与A组比较:B组MAP、HR于T1~T8时点较低(P<0.05),NTS处于D1~E2期患者较多(P<0.05);B组咪达唑仑用量较大(P<0.05),丙泊酚、舒芬太尼、瑞芬太尼及顺苯磺酸阿曲库铵用量较小(P<0.05); B组总入量较少(P<0.05),苏醒时间、拔管时间较短,Copper评分较高,Ramsay评分较低(P<0.05);B组副作用及并发症少,ICU停留时间及手术至出院时间短(P<0.05)。 结论 精细化麻醉管理使麻醉诱导与维持过程平稳,苏醒及时而完全,副作用及并发症少,患者术后转归好。

关键词: 麻醉; 盆腔肿瘤
Abstract:

Objective To study the clinical efficacy and safety of fine anesthetic management in general anesthesia for pelvic tumor patients who undergoing open surgery. Methods A total of 96 elective patients with pelvic tumors who need general anesthesia were selected. ASA Ⅰ-Ⅱ level was randomly divided into two groups: the experience group (group B, the control group) and the refined anesthesia management group (group B, the observation group), with 48 cases in each group. Patients in group B accept anesthesia management based on clinical experience of anesthesiologists, patients in group B accept anesthesia management based on index of instruments and equipment (including the guidance of anesthesia depth monitoring and closed-loop muscle relaxant injection system, heart function monitor). Time points setting as follows: 3 min after the Narcotrend (NT) numerical data in the room (T0), immediately after intubation (T1), into the abdomen (T2), resected immediately (T3), closing abdomen (T4), skin suture (T5), tracheal extubation (T6), consciousness recovery (T7), out of room (T8). MAP, HR and RR were recorded. Also, index as follows was recorded: SpO2, Narcotrend stage (NTS), Narcotrend index(NTI), myocutaneous count, train-of-four(TOF), stroke volume variation (SVV), anesthetic dosage, fluid volume, urine volume, intubation (according to the Copper score method), recovery time (stopping to call every time), extubation time (between withdrawal and extubation time), sedation score at leaving operation room, the adverse reactions, the time of stay in the ICU and the time from operation to discharge. Results Compared with group A, MAP and HR in group B were low at T1-T8 time (P<0.05). NTS was high in phase D1-E2 (P<0.05). In group B, the dosage of midazolam (P<0.05), propofol, sufentanil, remifentanil and atracurium sulfonate were small (P<0.05). Compared with group A, the total amount of group B was low(P<0.05). The time of awakening, the time of extubation was short. The Copper score was high. The Ramsay score was low (P<0.05). The adverse reactions and complications in group B were less than numbers in group A. The stay time in the guardianship and the time of discharge of patients in group B were shorter than the time in patients of group A (P<0.05). Conclusions The fine anesthesia management makes smooth induction and maintenance, timely and complete awakening, fewer adverse reactions and complications, better postoperative outcome. Thus, fine anesthesia is safe and feasible.

Key words: Anesthesia; Pelvic neoplasms